ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $40,510,000 | +38.3% | 435,870 | -11.4% | 0.03% | +33.3% |
Q3 2021 | $29,287,000 | -13.6% | 491,800 | -1.0% | 0.02% | -8.7% |
Q2 2021 | $33,882,000 | -3.1% | 496,800 | -1.4% | 0.02% | -4.2% |
Q1 2021 | $34,979,000 | -11.0% | 504,090 | -1.4% | 0.02% | -17.2% |
Q4 2020 | $39,299,000 | -1.0% | 511,500 | -3.6% | 0.03% | -12.1% |
Q3 2020 | $39,691,000 | +13.7% | 530,700 | -4.3% | 0.03% | +10.0% |
Q2 2020 | $34,910,000 | +43.3% | 554,570 | -4.4% | 0.03% | +25.0% |
Q1 2020 | $24,360,000 | -58.5% | 580,000 | -55.1% | 0.02% | -44.2% |
Q4 2019 | $58,637,000 | -6.2% | 1,291,000 | -5.5% | 0.04% | -14.0% |
Q3 2019 | $62,522,000 | -30.1% | 1,366,000 | -10.4% | 0.05% | -24.2% |
Q2 2019 | $89,422,000 | +36.4% | 1,525,200 | +4.3% | 0.07% | +37.5% |
Q1 2019 | $65,550,000 | +15.0% | 1,462,200 | -0.1% | 0.05% | +4.3% |
Q4 2018 | $57,023,000 | +25.4% | 1,464,000 | +48.1% | 0.05% | +48.4% |
Q3 2018 | $45,486,000 | – | 988,399 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |